Trade

Gujarat Inject Kerala share price

Balanced risk
  • 35%Low risk
  • 35%Moderate risk
  • 35%Balanced risk
  • 35%High risk
  • 35%Extreme risk
  • 57.60(1.95%)
    February 13, 2026 15:15:00 PM IST
    • NSE
    • BSE
  • Vol : 21.21 K (NSE + BSE)
    Last 20 day avg : 62.34 K

Gujarat Inject Kerala is trading 1.95% upper at Rs 57.60 as compared to its last closing price. Gujarat Inject Kerala has been trading in the price range of 57.63 & 56.50. Gujarat Inject Kerala has given 58.04% in this year & 6.72% in the last 5 days. The company posted a net profit of 0.07 Crores in its last quarter.Listed peers of Gujarat Inject Kerala include Sun Pharmaceutical Industries (-0.97%), Divi's Laboratories (-0.13%), Torrent Pharmaceuticals (-0.18%).The Mutual Fund holding in Gujarat Inject Kerala was at -% in . The MF holding has - from the last quarter. The FII holding in Gujarat Inject Kerala was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Feb 13, 2026, 01:28 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -1.71
    Low volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.43
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
56.50
Highest
57.63
52 week range
Lowest
17.02
Highest
56.69
Gujarat Inject Kerala Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Neutral
1,698.00-0.974,07,849.4233.295.31.000.50
Divi's Laboratories
Neutral
6,180.45-0.131,64,071.5373.2210.730.500.01
Torrent Pharmaceuticals
Bullish
4,074.05-0.181,37,562.0269.5417.660.8117.62
Cipla
Bearish
1,331.700.161,07,570.9720.313.430.980.81
Dr Reddy's Laboratories
Bullish
1,268.00-0.511,05,788.8317.933.020.662.34
Gujarat Inject Kerala Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-14Quarterly Results
2025-11-13Quarterly Results
2025-08-14Quarterly Results
2025-05-20Audited Results
2025-02-18Stock Split
About the company Gujarat Inject Kerala
  • IndustryBiotechnology & Drugs
  • ISININE659F01014
  • BSE Code524238
  • NSE Code
Gujarat Inject Kerala Limited is an India-based company. The Company is engaged in vegetable trading activities.
  • Management Info
  • Deepak BachwaniChief Financial Officer, Additional Executive Director
  • Manmeetkaur BhatiaCompany Secretary and Compliance Officer
Gujarat Inject Kerala Share Price FAQs

Gujarat Inject Kerala is trading at 57.60 as on Fri Feb 13 2026 09:45:00. This is 1.95% upper as compared to its previous closing price of 56.50.

The market capitalization of Gujarat Inject Kerala is 84.38 Cr as on Fri Feb 13 2026 09:45:00.

The 52 wk high for Gujarat Inject Kerala is 56.69 whereas the 52 wk low is 17.02

Gujarat Inject Kerala can be analyzed on the following key metrics -

  • TTM P/E: 69.04
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: 0.00

Gujarat Inject Kerala reported a net profit of 1.02 Cr in 2025.